Senderos the manufacturing of ALO-02 is similar to Embeda's one-bead delivery platform tech which means right now you cannot assume the stability issues have been fixed. In addition, and of greater concern, would be the fact that in a clinical study of 400 pts, 60% of the pts discontinued taking the drug during a 12-month period, 20-30% due to the drugs side effects. Elite's delivery system is two-bead which is far less likely to have these types of stability issues.